This research investigates the effectiveness of tacrolimus in treating steroid-refractory fulminant lymphocytic myocarditis guided by cardiac magnetic resonance imaging.
Utilized serial cardiac magnetic resonance imaging to monitor treatment response.
Administered tacrolimus in patients with steroid-refractory myocarditis.
Evaluated clinical outcomes based on imaging results.
Patients showed improved cardiac function as observed in follow-up imaging assessments.
Tacrolimus treatment led to significant symptom relief and quality of life improvements.
No severe adverse effects were reported during the treatment phase.